The target: The general analysis, strategy and methods of assessment of the pharmaceutical enterprise resp. the group of Zentiva as of 1.12.2008 and determination of its market value. Methods: The resulting assessment by the model DCF- two- phase models of FCFF and FCFE include predicted discounted cash flow ending in the year 2013 for the evaluation of the first phase. The conclusion: The analysis and determination of market value of the enterprise. The value of the group resp. the volume of consolidated revenues of the group is modified with assistance of simulation Monte Carlo.
| Identifer | oai:union.ndltd.org:nusl.cz/oai:invenio.nusl.cz:10549 |
| Date | January 2008 |
| Creators | Procházková, Olga |
| Contributors | Hnilica, Jiří, Sieber, Patrik |
| Publisher | Vysoká škola ekonomická v Praze |
| Source Sets | Czech ETDs |
| Language | Czech |
| Detected Language | English |
| Type | info:eu-repo/semantics/masterThesis |
| Rights | info:eu-repo/semantics/restrictedAccess |
Page generated in 0.002 seconds